Axsome Therapeutics, Inc. (AXSM)
NASDAQ · Healthcare
Axsome Therapeutics, Inc. annual/quarterly shareholder equity history from 2022 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Axsome Therapeutics, Inc. shareholder equity for the quarter ending December 31, 2025 were 88.3M, a 54.86% increase year-over-year.
- Axsome Therapeutics, Inc. shareholder equity for 2025 were 88.3M, a 54.86% increase from 2024.
- Axsome Therapeutics, Inc. shareholder equity for 2024 were 57.0M, a 70.15% decrease from 2023.
- Axsome Therapeutics, Inc. shareholder equity for 2023 were 191.0M, a 74.32% increase from 2022.
- Axsome Therapeutics, Inc. shareholder equity for 2022 were 109.6M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Axsome Therapeutics, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $88 |
| 2024 | $57 |
| 2023 | $191 |
| 2022 | $110 |
| Axsome Therapeutics, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $88 |
| 2024-12-31 | $57 |
| 2023-12-31 | $191 |
| 2022-12-31 | $110 |
Axsome Therapeutics, Inc. Shareholder Equity — FAQ
Axsome Therapeutics, Inc. (AXSM) shareholder equity over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AXSM's shareholder equity history?
The chart and table above show Axsome Therapeutics, Inc.'s shareholder equity by year and by quarter, including the growth rate.